NCT05619861 2022-11-17CAR-T Cells in the Treatment of Malignant Hematological TumorsHebei Senlang Biotechnology Inc., Ltd.Phase NA Unknown20 enrolled
NCT04162340 2021-05-19CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell MalignanciesiCell Gene TherapeuticsPhase 1 Unknown12 enrolled